AC Immune SA - SHS (ACIU)

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / SHS
Total 13F shares
11,284,927
Share change
+111,938
Total reported value
$116,687,000
Price per share
$10.34
Number of holders
18
Value change
+$956,972
Number of buys
9
Number of sells
8

Institutional Holders of AC Immune SA - SHS (ACIU) as of Q1 2018

As of 31 Mar 2018, AC Immune SA - SHS (ACIU) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,284,927 shares. The largest 10 holders included FMR LLC, Duquesne Family Office LLC, Temasek Holdings (Private) Ltd, PointState Capital LP, Artal Group S.A., Tekla Capital Management LLC, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, DEUTSCHE BANK AG\, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 18 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.